Geisinger Receives Funding to Enhance Cancer Patient Monitoring

Geisinger has been approved for funding by the Patient-Centered Outcomes Research Institute (PCORI) to implement electronic monitoring of patients’ self-reported symptoms during cancer treatment. Patients being treated for cancer often have symptoms such as fatigue, pain and nausea. Managing these symptoms, which can stem from both the disease and its treatment, is a key component of high-quality cancer care and can enhance patients’ well-being, decrease visits to the hospital and improve treatment adherence .

Led by H. Lester Kirchner, Ph.D. and Christian Adonizio, M.D., this project will implement Epic’s Electronic Symptom Management (eSyM) module for Geisinger patients receiving systemic chemotherapy, oral chemotherapy and radiation therapy. The work is based on findings from a PCORI- funded patient-centered comparative clinical effectiveness (CCE) study demonstrating improved symptom control, physical function, health-related quality of life and overall survival among patients who completed electronic patient-reported outcome surveys, as compared with those who received usual care.

Dr. Kirchner is professor and chair of the Department of Population Health Sciences in Geisinger’s Research Institute. He and Keith Boell, D.O., Geisinger’s chief quality officer, are project leads for Geisinger’s Health Systems Implementation Initiative (HSII) participation. Dr. Adonizio is a medical oncologist/hematologist, professor of medicine Geisinger College of Health Sciences, and the associate fellowship director for Geisinger’s Cancer Institute.

Geisinger was selected to participate in the HSII through a PCORI opportunity recruiting healthcare institutions to promote evidence-based practice based on findings generated from PCORI-funded patient-centered CCE. HSII aims to reduce the estimated 17-year gap between evidence publication and clinical application. This initiative recognizes that health systems’ practical experience and real- world insights are crucial for sustainable, large-scale implementation of practice-changing findings in clinical care.

The funding award has been approved pending completion of PCORI’s business and programmatic review and issuance of a formal award contract.